Juan J. Rojas
L'hospitalet De Llobregat, CT 08908, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Identification and evaluation of novel intergenic sites in the vaccinia virus genome for transgene insertion.
Journal: Molecular therapy. Oncology
Published: July 08, 2025
Bioinformatic analysis of molecular characteristics and oncogenic features of CARD14 in human cancer.
Journal: Scientific reports
Published: April 22, 2024
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 10, 2023
Biological basis of extensive pleiotropy between blood traits and cancer risk.
Journal: Genome medicine
Published: August 11, 2023
Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice.
Journal: Pathogens (Basel, Switzerland)
Published: May 07, 2023
Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease.
Journal: Cancer gene therapy
Published: September 19, 2022
Activation of interferon regulatory factor 3 by replication-competent vaccinia viruses improves antitumor efficacy mediated by T cell responses.
Journal: Molecular therapy oncolytics
Published: December 17, 2020
Recombinant viruses delivering the necroptosis mediator MLKL induce a potent antitumor immunity in mice.
Journal: Oncoimmunology
Published: September 14, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026